The Foundation for the National Institutes of Health Appoints Love Collins, III to Lead Advancement and Development
13 Mayo 2024 - 7:17AM
Business Wire
The Foundation for the National Institutes of Health (FNIH)
announces that Love Collins, III, has joined as Vice President of
Advancement. In this role, he will serve as the FNIH’s chief
development officer and will lead efforts to expand the portfolio
of resources and help accelerate the launch of new collaborative
biomedical research programs and related scientific efforts in
support of the NIH.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240510654691/en/
Love Collins, III, joins FNIH as Vice
President of Advancement (Photo: Business Wire)
“We are delighted that Mr. Collins is joining the FNIH team,”
said Julie Gerberding, MD, MPH, President and CEO of the FNIH. “As
our chief development officer, his experience in establishing
trustworthy relations with research investors and philanthropists
aligns perfectly with our mission and will help catalyze the
resources we need to expand the scope and impact of our scientific
portfolio.”
“I am honored to be a part of the exceptionally talented team at
the FNIH,” said Mr. Collins. “The FNIH is an amazing organization,
and I welcome the chance to help expand its public-private
partnerships that tackle the complex health challenges that no
single organization can solve on its own. Breakthroughs require
resources and trustworthy relationships, and I look forward to
contributing to both.”
With more than 30 years of experience in both the public and
private sectors, Mr. Collins has extensive expertise in
fundraising, strategic planning, and organizational development,
with particular emphasis in biomedical research and health science
philanthropy. He has successfully raised over $500 million for a
diverse range of nonprofit organizations.
Mr. Collins served as Vice Chancellor of Development and Alumni
Affairs at the University of Tennessee Health Science Center, where
he led a team in raising over $100 million in philanthropic
support. Mr. Collins also served as Vice President of Development
and Communications at the Van Andel Institute, where he increased
annual fundraising from $2 million to $7 million in support of
translational science and breakthrough research in cancer,
Parkinson’s disease, and epigenetics.
Mr. Collins’ career includes top leadership roles at
institutions such as Dillard University, Benedict College, Howard
University, Florida A&M University and Foundation, and the 1996
Atlanta Committee for the Olympic Games, where he served as deputy
managing director of operations.
Mr. Collins holds a bachelor’s degree in engineering from the
U.S. Military Academy at West Point and an MBA in finance from
Emory University, Goizueta Business School.
About the Foundation for the National Institutes of
Health
The Foundation for the National Institutes of Health (FNIH)
builds public-private partnerships that connect leading biomedical
scientists at the National Institutes of Health (NIH) with their
counterparts in life sciences companies, academia, patient
organizations, foundations, and regulatory agencies (including the
Food and Drug Administration and European Medicines Agency).
Through team science, the FNIH solves complex health challenges and
accelerates breakthroughs for patients, regardless of who they are
or what health threats they face. The FNIH contributes to the
development of new therapies, diagnostics, and potential cures;
advances global health and equity in care; and celebrates and helps
train the next generations of scientists. Established by Congress
in 1990 to support the mission of the NIH, the FNIH is a
not-for-profit 501(c)(3) charitable organization. For more
information about the FNIH, please visit fnih.org.
Follow us on social media: LinkedIn, X, Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240510654691/en/
Geralyn Laneve FNIH 301-827-6648 glaneve@fnih.org